| Name | Title | Contact Details |
|---|
Medikmark, Inc. was founded in 1987, and is now under the ownership of David H. Sanders. Medikmark is an FDA registered manufacturer maintaining a Class 100,000 clean room and 10,000 clean room and is a licensed drug wholesaler. Medikmark is also a small
Scientek Technology Corp. is a Delta, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Precision Optics Corporation has been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality medical instruments, micro optics and assemblies with sizes less than 1 millimeter, and other advanced optical systems. Our medical instrumentation line includes rigid laparoscopes, arthroscopes, sinuscopes, and a line of world-class 3-D endoscopes. We also design and build flexible fiber scopes with diameters as small as 5 microns with illumination for use in minimally invasive surgical procedures. We have a complete line of endocouplers with focal ranges from 20mm - 45mm and a parfocal zoom coupler with focal ranges from 20mm-37mm. We are registered to the ISO 9001:2008, ISO 13485:2003, CMDCAS Quality Standards, and comply with the FDA Good Manufacturing Practices and the European Union Medical Device Directive for CE marking of our medical products.
At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.
Health Care System Consultants, Inc is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.